Interferon lambda prevents melanoma growth in mice
  Type III interferons (IFN-lambda) exhibits potent anti-viral and immunomodulatory activities. They signal through  IFN-lambdaR1 (IFN-λR1) and interleukin receptor-2. Here we report the role of IFN-lambda (IFNλ) in regulation of melanoma growth using IFNλ receptor knockout (Ifnlr1-/-) mice. 
  Published in Biomedical Research
  
            
     Like
            
              Be the first to like this
            
        
    Our data demonstrates that IFN-lambda (IFN-λ) signaling prevents melanoma tumor growth and maintains the immune cell landscape within the tumor microenvironment. Ifnlr1-/- (IFN-lambda receptor knockout) mice revealed that the absence of IFN-λ signaling leads to a substantial increase in tumor weight and volume compared to wild-type C57BL/6 mice. Flow cytometry analysis of Ifnlr1-/- tumors showed notable differences in the following immune cell populations: Increased CD4+CD25+, decreased CD8+, and increased CD11b+Gr-1+ cells.
Follow the Topic
          
            
            
              Biomedical Research
            
          
          
  
            Life Sciences > Health Sciences > Biomedical Research
          
      
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in